SCHEMBL4552240

SCHEMBL4552240

Cc1ccc(Nc2cc(N3CCOCC3)cc(C(F)(F)F)c2)cc1-c1cc(C(=O)NCC(C)(C)C)on1

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 17/20 0.50
BRAF P15056 17/20 0.50
CSF1R P07333 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4552241 0.89 RAF1 (0.63) RAF1BRAFCSF1R
SCHEMBL4551892 0.88 RAF1 (0.44) RAF1BRAF
SCHEMBL5603943 0.87 RAF1 (0.45) RAF1BRAF
SCHEMBL5604225 0.87 BRAF (0.47) RAF1BRAFCSF1R
SCHEMBL5603594 0.86 CSF1R (0.48) RAF1BRAFCSF1R
SCHEMBL4552281 0.86 RAF1 (0.45) RAF1BRAFCSF1R
SCHEMBL4417023 0.84 RAF1 (0.56) RAF1BRAFCSF1R
SCHEMBL4412866 0.83 RAF1 (0.56) RAF1BRAFCSF1R
SCHEMBL4565794 0.83 CSF1R (0.60) RAF1BRAFCSF1R
SCHEMBL4551600 0.83 RAF1 (0.39) RAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed